Breaking News

Investindustrial Acquires Proveris Scientific

Proveris is a global provider for spray characterization testing instrumentation, lab services and OINDP expertise.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

An investment subsidiary of Investindustrial Growth III SCSp has acquired Proveris Scientific Corp., a designer and manufacturer of spray and aerosol testing instrumentation, software and lab solutions for the pharmaceutical industry.  Proveris specializes in orally inhaled and nasal drug products (OINDP).

Founded by Dino J. Farina, and headquartered in Hudson, MA, Proveris is a global provider for spray characterization testing instrumentation, lab services and OINDP expertise. Proveris’ technologies are embedded in customer workflows and regulatory processes, supporting reproducibility and data continuity. The company serves a diverse and global customer base of branded and generic pharmaceutical companies, contract development organizations, device makers and regulatory agencies. 

Through its investment in and in partnership with Proveris’ management, Investindustrial aims to further expand Proveris’ pharmaceutical testing equipment group through organic growth and acquisitions in its existing markets and in adjacent pharmaceutical testing equipment categories. 

Founder Dino Farina, a pioneer in the OINDP testing equipment industry, will remain with Proveris and has reinvested as a minority shareholder alongside Investindustrial.

Andrea C. Bonomi, Chairman of the Investindustrial Industrial Advisory Board, said: “Proveris represents an exceptional platform to build a global leader in specialty pharmaceutical testing equipment. We greatly admire what Dino and the team have achieved and look forward to partnering on the next phase of growth. By leveraging our industrial expertise, international reach, and strong integration capabilities, we aim to accelerate growth and expand the company’s global footprint.”

Dino Farina, Founder & CEO of Proveris, said: “Investindustrial represents everything I could hope for in a partner focused on strategic growth, investment and value creation for Proveris’ customers and the Proveris team. I am very excited for the future working with the Investindustrial team.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics